Our intensive longitudinal sampling during Omicron BA.2 breakthrough infection revealed the early dynamics of specific antibody levels (IgG/IgM/IgA) against the ancestral Hu-1 SARS-CoV-2 S protein. The gene discussed is CD79A; the disease is infection.